Abstract
Benzopyrone derivatives (Coumarins) are well known inhibitors of P-glycoprotein (P-gp) mediated efflux. The high expression level of these efflux proteins promotes the growth of breast cancer stem cells (CSCs). The activity of breast CSCs is directly affected by the inhibition of efflux proteins by benzopyrone derivatives. Ligand based pharmacophoric study and structure based docking studies have been exploited for assessing this inhibitory activity. Based on QSAR results, a three point pharmacophore comprising of one hydrogen bond acceptor (A) and two condensed aromatic groups (R) has been designed. The atom based QSAR study was conducted to predict partial least square (PLS) statistical factors for test and training data sets. Some specific amino acids have been demonstrated to be actively involved in the ligand protein interaction. These structural features of ligands and active site residues of target protein provide new pathways to develop therapeutically important drugs for the inhibition of breast cancer stem cells.
Keywords: Breast cancer stem cells, P-glycoprotein (P-gp), Efflux, Quantitative structure activity relationship (QSAR), Benzopyrones.
Current Bioinformatics
Title:3D-QSAR and Docking Simulation Studies of Some Benzopyrone Derivatives as Inhibitors for Breast Cancer Stem Cell Growth via PGlycoprotein Mediated Efflux
Volume: 11 Issue: 3
Author(s): Anushree Tripathi and Krishna Misra
Affiliation:
Keywords: Breast cancer stem cells, P-glycoprotein (P-gp), Efflux, Quantitative structure activity relationship (QSAR), Benzopyrones.
Abstract: Benzopyrone derivatives (Coumarins) are well known inhibitors of P-glycoprotein (P-gp) mediated efflux. The high expression level of these efflux proteins promotes the growth of breast cancer stem cells (CSCs). The activity of breast CSCs is directly affected by the inhibition of efflux proteins by benzopyrone derivatives. Ligand based pharmacophoric study and structure based docking studies have been exploited for assessing this inhibitory activity. Based on QSAR results, a three point pharmacophore comprising of one hydrogen bond acceptor (A) and two condensed aromatic groups (R) has been designed. The atom based QSAR study was conducted to predict partial least square (PLS) statistical factors for test and training data sets. Some specific amino acids have been demonstrated to be actively involved in the ligand protein interaction. These structural features of ligands and active site residues of target protein provide new pathways to develop therapeutically important drugs for the inhibition of breast cancer stem cells.
Export Options
About this article
Cite this article as:
Tripathi Anushree and Misra Krishna, 3D-QSAR and Docking Simulation Studies of Some Benzopyrone Derivatives as Inhibitors for Breast Cancer Stem Cell Growth via PGlycoprotein Mediated Efflux, Current Bioinformatics 2016; 11 (3) . https://dx.doi.org/10.2174/1574893611999160610125100
DOI https://dx.doi.org/10.2174/1574893611999160610125100 |
Print ISSN 1574-8936 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-392X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Sexual Dimorphism in Autoimmune Disease
Current Molecular Medicine Use of Intravenous Immunoglobulin in the Treatment of Immune-Mediated Demyelinating Diseases of the Nervous System
Current Pharmaceutical Design Chemokines as Pharmacological Targets
Mini-Reviews in Medicinal Chemistry Recent Advances in the Development of Phytoestrogens and Derivatives: An Update of the Promising Perspectives in the Prevention of Postmenopausal Diseases
Mini-Reviews in Medicinal Chemistry MicroRNA Regulation in Cardiovascular Disease
Current Drug Targets Update on the Development of microRNA and siRNA Molecules as Regulators of Cell Physiology
Recent Patents on DNA & Gene Sequences Angiotensin Converting Enzyme Inhibitory Peptides Derived from Food Proteins: Biochemistry, Bioactivity and Production
Current Pharmaceutical Design Bioinformatics Approach to BDNF and BDNF-Related Disorders
Current Neuropharmacology Advancement in Microbial Cheminformatics
Current Topics in Medicinal Chemistry Genetic Polymorphism and Tumor Immunotherapy
Current Pharmacogenomics Mediterrranean Diet and Health Biological Importance of Olive Oil
Current Pharmaceutical Design The Potential Role of Claudins in Regulation of Metastasis and Development of Drug Resistance in Breast Cancer
Clinical Cancer Drugs Secondary Metabolites from Cordyceps Species and Their Antitumor Activity Studies
Recent Patents on Biotechnology Recent Approaches to Improve the Antitumor Efficacy of Temozolomide
Current Medicinal Chemistry Docetaxel-loaded Bovine Serum Albumin Nanoparticles Conjugated Docosahexaenoic Acid for Inhibiting Lung Cancer Metastasis to Bone
Anti-Cancer Agents in Medicinal Chemistry Signal Transduction Therapy in Pancreatic Cancer
Current Signal Transduction Therapy Lifestyle Factors and MicroRNAs: A New Paradigm in Cancer Chemoprevention
MicroRNA Mutations of Chromatin Structure Regulating Genes in Human Malignancies
Current Protein & Peptide Science Gold(III) Complexes in the Oncological Preclinical Arena: From Aminoderivatives to Peptidomimetics
Current Topics in Medicinal Chemistry Targeting Tumors Using Estrogen Receptor Ligand Conjugates
Current Cancer Drug Targets